0
Correspondence and Brief Communications |

Somatostatin Receptor Scintigraphy and Endoscopic Ultrasonography for Occult Carcinoid Tumor

Carmine Volpe, MD; Ralph J. Doerr, MD
Arch Surg. 1999;134(5):575-576. doi:.
Text Size: A A A
Published online

Extract

We read with interest the report by Rubio et al1 on "Carcinoid Tumor Metastatic to the Breast" in the October 1998 ARCHIVES. We agree that the presentation is consistent with carcinoid tumor metastatic to the breast; however, consideration should be given to the addition of serum chromogranin A, the somatostatin receptor for scintigraphy, and endoscopic ultrasonography to elucidate the occult primary carcinoid tumor. Chromogranin A is a valuable serum marker for neuroendocrine tumors, with the highest values found in patients with metastatic carcinoids of unknown primary sites. A correlation has been demonstrated between serum chromogranin A levels and somatostatin receptor positivity for midgut carcinoids.2 Evaluation for occult foregut carcinoid tumor should include endoscopic ultrasonography, which has a sensitivity of approximately 90% for tumors smaller than 2 cm.3 Scintigraphy combines the advantage of whole-body imaging with sensitivity of 75% to 100% and specificity of 90% to 100% to detect the unknown primary tumor and other sites of metastasis.4 Following external scintigraphy, gamma-detection probes can be employed intraoperatively to assist in the detection of nonpalpable (<5 mm), surgically occult lesions. 5

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();